BACKGROUND The prevalence of osteoporosis and low bone mass is steadily rising each year.Low body weight is commonly linked to diminished bone mass and serves as a robust predictor of osteoporosis.Nonetheless,the conn...BACKGROUND The prevalence of osteoporosis and low bone mass is steadily rising each year.Low body weight is commonly linked to diminished bone mass and serves as a robust predictor of osteoporosis.Nonetheless,the connection between body mass index(BMI),bone mineral density,and lipid profiles among the elderly remains elusive.AIM To examine the association between BMI and bone mass,explore the correlation between lipid profiles and bone mass,and delve into the interplay between lipid metabolism and bone health.METHODS The study included 520 patients aged≥65 years(178 men and 342 women).Age,sex,weight,and height were recorded.Femoral neck bone mineral density and T scores were determined using a dual-energy X-ray absorptiometry scanner.Blood calcium(Ca),phosphorus(P),albumin(ALB),alkaline phosphatase(ALP),aspartate aminotransferase,alanine aminotransferase,triglyceride(TG),total cholesterol(TC),high-density lipoprotein(HDL)and low-density lipoprotein(LDL)levels were measured.Patients were classified by sex(male and female),age(65-79 years and≥80 years),and T score(normal bone mineral density,osteopenia and osteoporosis).RESULTS Age,sex,BMI,and ALP and TG levels were independent risk factors for osteoporosis.For the 65-79-and≥80-yearold groups,females presented lower T scores than males.Ca,P,ALB,ALP,TC,HDL and LDL levels were significantly different between men and women in the 65-79-year-old group.In addition,BMI and TG levels were significantly decreased in osteoporotic patients compared with patients with normal bone mass.TC levels declined in 65-to 79-year-old male and female osteoporosis patients.In the group of women aged≥80 years,osteoporotic patients showed significantly increased ALP levels.Furthermore,we found positive correlations between BMI and TG levels in the male and female patient groups.However,we found no significant differences in ALB,Ca,P,HDL and LDL levels in osteoporotic patients compared to patients with normal bone mass.CONCLUSION Osteoporotic patients showed significantly decreased BMI and TG levels compared with those with normal bone mass.BMI showed positive correlations with TG levels in male and female patients.These results indicate correlations between BMI and bone mass and between lipid profiles and bone mass.展开更多
目的:基于网络药理学方法探讨巴元明治疗慢性肾功能衰竭(chronic renal failure,CRF)核心药物的作用机制。方法:通过中医药整合药理学研究平台(integrative pharmacology-based research platform of traditional Chinese medicine,TCMI...目的:基于网络药理学方法探讨巴元明治疗慢性肾功能衰竭(chronic renal failure,CRF)核心药物的作用机制。方法:通过中医药整合药理学研究平台(integrative pharmacology-based research platform of traditional Chinese medicine,TCMIP)V2.0数据库检索巴元明治疗CRF核心药物(黄芪、党参、生地黄、山药、山茱萸、茯苓、白茅根、茜草、金樱子、芡实、黄柏、穿山龙)的化学成分,进而筛选核心药物的作用靶点。从TCMIP V2.0数据库获取CRF疾病靶点,将核心药物作用靶点与CRF疾病靶点进行匹配,所得靶点即为核心靶点。通过TCMIP V2.0数据库构建核心药物作用靶点与CRF疾病靶点的蛋白质-蛋白质相互作用(protein-protein interaction,PPI)网络,计算网络拓扑特征值从而筛选关键靶点。构建“核心药物-活性成分-关键靶点”的多维关系网络,采用David v 6.7数据库进行基因本体(gene ontology,GO)和京都基因与基因组百科全书(Kyoto encyclopedia of genes and genomes,KEGG)富集分析。结果:12个核心药物含有356个活性成分,CRF相关疾病靶点13个;将核心药物作用靶点与CRF疾病靶点进行匹配,得到136个核心靶点;经过拓扑分析筛选得到62个关键靶点,包括腺苷酸环化酶1、多巴胺D2受体、蛋白激酶B1等;GO分析共获得170个功能(P<0.01),包括信号转导、凋亡过程负调控、细胞色素C氧化酶活性等;KEGG分析共获得105条通路(P<0.05),包括神经活性配体-受体相互作用、近端小管对钠离子的重吸收、代谢通路、Ras信号通路等。结论:巴元明治疗CRF的核心药物具有多成分、多靶点、多途径的作用特点,其可作用于腺苷酸环化酶1、多巴胺D2受体、热休克蛋白αA1等靶点,调控近端小管对钠离子的重吸收、代谢通路、Ras信号通路等通路。展开更多
基金Supported by Jiangsu Elderly Health Research Project,No.LD2021010Jiangsu Elderly Health Research Project,Key Project of Elderly Health Research Project,No.LKZ2022010Open Project of National Key Professional Base for Standardized Training of Resident Physicians in Zhongda Hospital Affiliated to Southeast University,No.ZDZYJD-QK-2022-7.
文摘BACKGROUND The prevalence of osteoporosis and low bone mass is steadily rising each year.Low body weight is commonly linked to diminished bone mass and serves as a robust predictor of osteoporosis.Nonetheless,the connection between body mass index(BMI),bone mineral density,and lipid profiles among the elderly remains elusive.AIM To examine the association between BMI and bone mass,explore the correlation between lipid profiles and bone mass,and delve into the interplay between lipid metabolism and bone health.METHODS The study included 520 patients aged≥65 years(178 men and 342 women).Age,sex,weight,and height were recorded.Femoral neck bone mineral density and T scores were determined using a dual-energy X-ray absorptiometry scanner.Blood calcium(Ca),phosphorus(P),albumin(ALB),alkaline phosphatase(ALP),aspartate aminotransferase,alanine aminotransferase,triglyceride(TG),total cholesterol(TC),high-density lipoprotein(HDL)and low-density lipoprotein(LDL)levels were measured.Patients were classified by sex(male and female),age(65-79 years and≥80 years),and T score(normal bone mineral density,osteopenia and osteoporosis).RESULTS Age,sex,BMI,and ALP and TG levels were independent risk factors for osteoporosis.For the 65-79-and≥80-yearold groups,females presented lower T scores than males.Ca,P,ALB,ALP,TC,HDL and LDL levels were significantly different between men and women in the 65-79-year-old group.In addition,BMI and TG levels were significantly decreased in osteoporotic patients compared with patients with normal bone mass.TC levels declined in 65-to 79-year-old male and female osteoporosis patients.In the group of women aged≥80 years,osteoporotic patients showed significantly increased ALP levels.Furthermore,we found positive correlations between BMI and TG levels in the male and female patient groups.However,we found no significant differences in ALB,Ca,P,HDL and LDL levels in osteoporotic patients compared to patients with normal bone mass.CONCLUSION Osteoporotic patients showed significantly decreased BMI and TG levels compared with those with normal bone mass.BMI showed positive correlations with TG levels in male and female patients.These results indicate correlations between BMI and bone mass and between lipid profiles and bone mass.
文摘目的:基于网络药理学方法探讨巴元明治疗慢性肾功能衰竭(chronic renal failure,CRF)核心药物的作用机制。方法:通过中医药整合药理学研究平台(integrative pharmacology-based research platform of traditional Chinese medicine,TCMIP)V2.0数据库检索巴元明治疗CRF核心药物(黄芪、党参、生地黄、山药、山茱萸、茯苓、白茅根、茜草、金樱子、芡实、黄柏、穿山龙)的化学成分,进而筛选核心药物的作用靶点。从TCMIP V2.0数据库获取CRF疾病靶点,将核心药物作用靶点与CRF疾病靶点进行匹配,所得靶点即为核心靶点。通过TCMIP V2.0数据库构建核心药物作用靶点与CRF疾病靶点的蛋白质-蛋白质相互作用(protein-protein interaction,PPI)网络,计算网络拓扑特征值从而筛选关键靶点。构建“核心药物-活性成分-关键靶点”的多维关系网络,采用David v 6.7数据库进行基因本体(gene ontology,GO)和京都基因与基因组百科全书(Kyoto encyclopedia of genes and genomes,KEGG)富集分析。结果:12个核心药物含有356个活性成分,CRF相关疾病靶点13个;将核心药物作用靶点与CRF疾病靶点进行匹配,得到136个核心靶点;经过拓扑分析筛选得到62个关键靶点,包括腺苷酸环化酶1、多巴胺D2受体、蛋白激酶B1等;GO分析共获得170个功能(P<0.01),包括信号转导、凋亡过程负调控、细胞色素C氧化酶活性等;KEGG分析共获得105条通路(P<0.05),包括神经活性配体-受体相互作用、近端小管对钠离子的重吸收、代谢通路、Ras信号通路等。结论:巴元明治疗CRF的核心药物具有多成分、多靶点、多途径的作用特点,其可作用于腺苷酸环化酶1、多巴胺D2受体、热休克蛋白αA1等靶点,调控近端小管对钠离子的重吸收、代谢通路、Ras信号通路等通路。
